Insmed (INSM) said Thursday it will redeem June 6 the entire $569.5 million aggregate principal amount of its remaining outstanding 0.75% Convertible Senior Notes due 2028.
The company will pay the redemption price in cash and equal to 100% of the principal amount of the notes outstanding on the redemption date, plus accrued and unpaid interest on the notes to, but excluding, the redemption date.
If noteholders choose to convert their notes to common shares, the company has elected to settle the conversions at any time prior to 5 pm ET June 4. As of April 24, the conversion rate of the notes is 30.7692 shares of common stock of the company per $1,000 principal amount of the notes, equivalent to a conversion price of about $32.50 per share.
Based on this conversion rate, an aggregate of up to 17.5 million common shares will be issued if all of the notes are converted, the company said.
Price: 69.55, Change: -1.25, Percent Change: -1.77
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。